Showing 3461-3470 of 8226 results for "".
New Expectations in the Patient Experience
https://crstoday.com/topics/practice-management/new-expectations-in-the-patient-experience/44172/Valuable information on what patients expect from their surgical journey.Endophthalmitis Prophylaxis: What’s Changed?
https://crstoday.com/crst-issues/sept-2021/endophthalmitis-prophylaxis-whats-changed/44552/In the 20 years since CRST’s first issue, more specifics on the treatment of this infection have been elucidated, and eye surgeons are on the cusp of optimizing the use of antibiotics.New Strategies in the Diagnosis and Management of Ocular Allergy
https://crstoday.com/topics/general/new-strategies-in-the-diagnosis-and-management-of-ocular-allergy/42319/Identifying allergens and teaching patients how to avoid or reduce their exposure can be a helpful first step.The STAAR Toric IOL
https://crstoday.com/topics/general/crst0506_14-html/41040/Current technique and results with a plate-haptic lens that effectively neutralizes corneal astigmatism at the time of cataract surgery.Global HIV/AIDS and Visual Impairment
https://crstoday.com/topics/refractive-surgery/crst1005_17-php/40696/Current worldwide trends of HIV/AIDS and the management of blinding ocular complications in the developing world.Bargain No More
https://crstoday.com/topics/general/bargain-no-more/42609/The maddening costs of generic medications.Data-Driven Ophthalmology
https://crstoday.com/crst-issues/nov-dec-2024/data-driven-ophthalmology/45402/How to harness precision tools and machine learning in cataract and refractive surgery.IOL Calculations in Patients With Keratoconus
https://crstoday.com/crst-issues/apr-2022/iol-calculations-in-patients-with-keratoconus/44700/Biometry tends to be less accurate in these individuals than in the general population.Noncovered Services Related to Premium IOLs
https://crstoday.com/crst-issues/2020-oct/noncovered-services-related-to-premium-iols/44345/Understand the relevant rulings by CMS.The Role of Growth Factor in DED
https://crstoday.com/topics/ocular-surface-disease/the-role-of-growth-factor-in-ded/44293/Regenerative therapies expand the options for patients who do not respond to conventional therapies.